See more : Biofrontera AG (0DOL.L) Income Statement Analysis – Financial Results
Complete financial analysis of Xinyaqiang Silicon Chemistry Co.,Ltd (603155.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Xinyaqiang Silicon Chemistry Co.,Ltd, a leading company in the Chemicals industry within the Basic Materials sector.
- Hamelin Gold Limited (HMG.AX) Income Statement Analysis – Financial Results
- Zordix AB (publ) (ZORDIX-B.ST) Income Statement Analysis – Financial Results
- Yes Optoelectronics (Group) Co., Ltd. (002952.SZ) Income Statement Analysis – Financial Results
- PT Jobubu Jarum Minahasa TBK (BEER.JK) Income Statement Analysis – Financial Results
- Grand Brilliance Group Holdings Limited (8372.HK) Income Statement Analysis – Financial Results
Xinyaqiang Silicon Chemistry Co.,Ltd (603155.SS)
About Xinyaqiang Silicon Chemistry Co.,Ltd
Xinyaqiang Silicon Chemistry Co.,Ltd manufactures and sells organic silicon methylsilane and phenyl products. It offers hexamethyldisiloxane, iodotrimethylsilane, chlorotrimethylsilane, hexamethyldisilane, diethoxydimethylsilane, dimethoxydimethylsilane, phenyltrichlorosilane, dichlorodiphenylsilane, dichlorodimethylsilane, trimethylethoxysilane, methyltrimethoxysilane, and methyltriethoxysilane; 1,3-divinyltetramethyldisilazane; 1,3-diethenyl-1,1,3,3-tetramethyldisiloxane; N,1,1,1-tetramethyl-N-(trimethylsilyl)silylamine; 1,1,1,3,3,3-hexamethyldisilazane; and 1,3-Bis(trimethylsilyl)urea. The company was founded in 2009 and is based in Suqian, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 675.20M | 1.13B | 880.00M | 490.33M | 601.95M | 650.02M | 267.40M | 191.96M | 169.53M | 179.91M | 211.81M |
| Cost of Revenue | 510.05M | 785.39M | 502.21M | 288.01M | 304.00M | 343.88M | 155.49M | 120.70M | 115.11M | 108.41M | 170.06M |
| Gross Profit | 165.15M | 348.21M | 377.78M | 202.32M | 297.95M | 306.14M | 111.91M | 71.27M | 54.41M | 71.50M | 41.75M |
| Gross Profit Ratio | 24.46% | 30.72% | 42.93% | 41.26% | 49.50% | 47.10% | 41.85% | 37.13% | 32.10% | 39.74% | 19.71% |
| Research & Development | 33.40M | 36.86M | 28.16M | 18.03M | 25.12M | 20.04M | 9.18M | 16.07M | 7.63M | 7.50M | 8.71M |
| General & Administrative | 3.73M | 2.72M | 4.08M | 5.35M | 5.55M | 25.24M | 3.75M | -7.14M | 18.55M | 2.51M | 3.17M |
| Selling & Marketing | 1.46M | 3.43M | 2.64M | 2.28M | 9.08M | 7.52M | 6.60M | 6.07M | 4.83M | 4.19M | 3.28M |
| SG&A | 5.19M | 6.15M | 6.72M | 7.63M | 14.64M | 32.76M | 10.35M | -1.07M | 17.05M | 6.70M | 6.44M |
| Other Expenses | -12.29M | 21.68M | 18.52M | 18.10M | 17.45M | 1.01M | 1.81M | 3.63M | 0.00 | 3.95M | 1.14M |
| Operating Expenses | 26.30M | 64.69M | 53.40M | 43.76M | 57.21M | 67.47M | 27.62M | 25.36M | 16.73M | 21.87M | 20.74M |
| Cost & Expenses | 536.35M | 850.08M | 555.61M | 331.77M | 361.21M | 411.35M | 183.11M | 146.05M | 131.84M | 130.28M | 190.81M |
| Interest Income | 14.19M | 8.65M | 3.72M | 10.02M | 5.99M | 1.97M | 140.18K | 108.56K | 3.35M | 981.36K | 412.97K |
| Interest Expense | 844.18K | 233.53K | 185.94K | 0.00 | 135.33K | 931.41K | 2.54M | 2.31M | 0.00 | 5.31M | 5.21M |
| Depreciation & Amortization | 47.01M | 38.11M | 24.83M | 23.81M | 22.24M | 15.93M | 14.13M | 12.04M | 12.29M | 11.85M | 5.77M |
| EBITDA | 189.15M | 385.01M | 394.18M | 206.73M | 274.93M | 266.71M | 94.18M | 55.75M | 47.63M | 61.47M | 22.24M |
| EBITDA Ratio | 28.01% | 30.75% | 44.59% | 39.39% | 45.59% | 41.20% | 36.37% | 33.53% | 28.09% | 37.01% | 12.36% |
| Operating Income | 138.85M | 346.35M | 366.79M | 173.78M | 251.71M | 248.71M | 75.67M | 37.77M | 35.33M | 43.71M | 10.12M |
| Operating Income Ratio | 20.56% | 30.55% | 41.68% | 35.44% | 41.82% | 38.26% | 28.30% | 19.67% | 20.84% | 24.30% | 4.78% |
| Total Other Income/Expenses | 2.45M | 61.37M | 2.56M | 9.13M | 12.60M | 1.01M | -2.62M | 3.63M | -992.94K | 3.95M | -5.80M |
| Income Before Tax | 141.30M | 346.40M | 369.35M | 182.92M | 252.48M | 249.72M | 77.48M | 41.40M | 34.34M | 47.66M | 11.26M |
| Income Before Tax Ratio | 20.93% | 30.56% | 41.97% | 37.30% | 41.94% | 38.42% | 28.97% | 21.56% | 20.26% | 26.49% | 5.32% |
| Income Tax Expense | 18.20M | 44.77M | 49.91M | 25.58M | 33.06M | 38.57M | 11.25M | 5.93M | 5.02M | 5.12M | 1.65M |
| Net Income | 123.44M | 301.72M | 319.44M | 157.34M | 219.42M | 211.15M | 66.23M | 35.47M | 29.32M | 42.54M | 9.61M |
| Net Income Ratio | 18.28% | 26.62% | 36.30% | 32.09% | 36.45% | 32.48% | 24.77% | 18.48% | 17.30% | 23.65% | 4.54% |
| EPS | 0.39 | 1.34 | 1.42 | 0.70 | 0.97 | 1.34 | 0.42 | 0.23 | 0.19 | 0.40 | 0.08 |
| EPS Diluted | 0.39 | 1.34 | 1.42 | 0.70 | 0.97 | 1.34 | 0.42 | 0.23 | 0.19 | 0.40 | 0.08 |
| Weighted Avg Shares Out | 315.79M | 225.56M | 225.56M | 225.56M | 225.56M | 157.82M | 157.44M | 153.47M | 151.85M | 106.35M | 126.62M |
| Weighted Avg Shares Out (Dil) | 315.79M | 225.56M | 225.56M | 225.56M | 225.56M | 157.82M | 157.44M | 153.47M | 151.85M | 106.35M | 126.62M |
Source: https://incomestatements.info
Category: Stock Reports